Live markets
BTC ETH SOL BNB XRP DOGE
View all markets

Stellar Demand Of Qubetics Whitelist Outpaces Avalanche and Polygon

Stellar Demand Of Qubetics Whitelist Outpaces Avalanche and Polygon

With the crypto landscape being wrought with the volatility of some coins, it’s easy for investors to get frustrated. It might feel like you’re going to be as rich as Scrooge McDuck one day while the other days, you might feel like you’re going to lose it all. This only happens when you don’t conduct proper research and invest in a coin that is very susceptible to market forces. 

It can get overwhelming when you have so many options to choose from. Coins like Avalanche(AVAX) and Polygon(MATIC) may seem like good investment options. However, if you are looking for a brand-new coin untainted by market forces, then Qubetics(TICS) is the coin for you. While you’ll have to wait a little while longer to get your hands on the coin, the wait can be minimized by signing up for the Qubetics Whitelist. 

BtcTurk Exchange Pulls Down Price Of Avalanche

June 2024 saw yet another crypto exchange being targeted by a security breach. Turkey’s largest crypto exchange BtcTurk saw a culprit moving 1.96M AVAX to Coinbase/THORChain. This breach led to a 10% dip in the price of Avalanche(AVAX). The unauthorized withdrawals led to losses for the exchange as according to BtcTurk, the majority of user funds were secured in cold storage. Nonetheless, the price dip spooked investors who rushed towards the Qubetics Whitelist to find a safer and more scalable coin for their investments. 

Analysts Say This Is Not The Right Time To Buy Matic 

Polygon(MATIC) has found itself squarely rooted in the bear phase, with indications that the price might go even lower than its current levels which are already regarded as being too low. The last time that the coin hit or surpassed the $1 mark was in March 2024. Since then the coin has been struggling to gain footing. The Sharpe Ratio of any coin determines if the gains are worth it compared to the risk being exhibited. A positive ratio indicates that the risk-to-reward ratio is worth it. With Polygon’s reading being -2.16, analysts say now is not a good time to invest in the coin. 

Become An Early Investor In Qubetics 

Led by an extraordinary blockchain expert who also possesses a rich background in biomedical sciences, Qubetics has won over even the most skeptical of investors. The Layer 1 blockchain structure places users at the center of its operations and empowers them to influence the community from the very start. Signing up for the Qubetics Whitelist gives you early bird benefits including exclusive access to the presale where you can buy the coins for a lower price. 

Join The Qubetics Whitelist ASAP!

While other coins in the marketplace are dealing with legal issues and security breaches. Qubetics(TICS) has been impressing everyone with its forward-thinking approach. All seasoned investors who can tell the worth of an exciting new venture have put down their names on the Whitelist and you too can join their ranks. Qubetics awards active participation and it’s your time to shape up the Qubetics(TICS)  community as an early investor however you deem fit. 

Conclusion

As Qubetics nears the launch of its presale, spots are going away fast for its Whitelist. Joining the Whitelist is an exclusive privilege that will be afforded only to a select few and you can be one of them. Sign up now! 

https://lh7-us.googleusercontent.com/docsz/AD_4nXfDoWXChvfuoR-XC-sqrqiqNMwmckvKaeIrhMtNjr4KL0YFl1l0sthk4mgKBAMCokqkay4AnQHy9UUH1vBtmflm1qmmHaKKPicF-IUmnKOXgc19PNwppz3VcLAW1KHirtwkBfhWhwjskq1pcR7Yv0iP-vY?key=qDtf6qr73ADj605bXVWlzw

Join Qubetics Whitelist Today:

Whitelist: Qubetics.com 

Twitter: https://twitter.com/qubetics 

Telegram: https://t.me/qubetics  

Disclaimer: Any information written in this press release does not constitute investment advice. Optimisus does not, and will not endorse any information about any company or individual on this page. Readers are encouraged to do their own research and base any actions on their own findings, not on any content written in this press release. Optimisus is and will not be responsible for any damage or loss caused directly or indirectly by the use of any content, product, or service mentioned in this press release.